And no amount of denigration, challenges, board sackings will...

And no amount of denigration, challenges, board sackings will make any difference either, Dentie.
The hard work has been done, the 2 year plan for divestment and development is well underway, new products are arriving on the scene and the divestment is complete while retaining complete control of the patents and the research they signify.

Let me take you back to the 2013/2014 era where a capital raising was met with a very muted response from shareholders.
This meant a change of course in the MK development from full blown fully developed Stage 3 Clinical trials requiring piles of money to a more easily obtained completion of Pre Clinical Trials with possible partnerships in order to continue. This came to a monetary expense conclusion with the divestment.

Luckily for us the CEO was fortunate in obtaining the assets of Advangen for us. At the time it was looked upon as an alternative source of income to help bolster the predicted PEB royalties which later proved to be a lot less than required due to the bureaucratic quagmire in the USA.

This "nightmare" in turn led to another decision to fully develop the "shampoo" to an extensive and innovative range of hair and skin care products.
Further developments resulted in the synthetic aptamer being invented to allow the specific inhibiting of the FGF5 gene as opposed to blanket coverage hitting everything else as well. This is where 7 years of research and development have been heading with the resulting products now being firmly established in the Japanese market with sellouts on QVC from the new RED EX and from what we can establish China has picked up the run rate quite considerably.

The whole world has changed and if anyone thinks it will be all back to normal might do well to sit down and have a nice cup of Earl Grey and a scone while they are still available and keep the stress levels down. " Oh wait, don't Advangen have something for that?"